Heart Failure Testing Market

Heart Failure Testing Market Overview

Nowadays, cardiovascular diseases become common disease affected the older population. Cardiovascular diseases such as heart attack and heart failure are the common cause of mortality and growing at a rapid rate with time as lifestyle changes. According to NHS Foundation, more than 26 Mn population worldwide have heart failure in 2015.

Heart failure is a condition due to which the heart can’t able to pump blood properly. Researcher and manufacturer are focusing on developing effective and efficient diagnostic methods and devices to earlier diagnostic of heart failure. Most prominently diagnostic preferences available for heart failure diagnostics are electrocardiogram and blood tests. Electrocardiogram is the most commonly used method for heart failure testing.

Heart Failure Testing Market: Drivers and Restraints

Growing adoption of unhealthy lifestyles such as growing consumption tobacco and cigarette, unhealthy food, and growing body mass index boost up the growth of heart failure testing as an increasing number of cases of heart failure. Growing prevalence of diseases such as hypertension and diabetes are the most common factors favour the growth of the heart failure testing market.

Growing prevalence of coronary artery diseases is another factor expected to propel the growth of the heart failure testing market. The growing number of ageing population and obesity rate is the major factor influencing the growth of the heart failure testing market.

Technological advancement, the launch of the new product, growing research and development activities expected to boost up the growth of the heart failure testing market. The growing number of cardiovascular testing programs and awareness program for the general population boost up the growth of the heart failure testing market.

Moreover, some factors such as low reimbursement rate for heart failure testing procedures expected to restrain the growth of heart failure testing market. As well as low awareness regarding the risk of heart failure in the population of low and middle-income countries expected to hamper the growth of the heart failure testing market.

Heart Failure Testing Market: Overview

Heart failure testing market is segmented into electrocardiogram and blood test by product type. B-type natriuretic peptide (BNP) and NT-proBNP are most commonly used biomarkers to determine heart failure. Rapid diagnostic testing and laboratory testing both can be performed for heart failure testing. Based on products type, heart failure testing market is segmented into instruments, reagent, and POC testing kits.

Heart Failure Testing Market: Region-wise Outlook

North America expected to dominate the heart failure testing market as increasing usage of new technogies for heart failure testing. Europe expected to contribute the second-highest revenue share in the heart failure testing as increasing regular testing for cardiovascular diseases and growing adoption cardiac biomarkers for the effective treatment option.

Asia Pacific heart failure testing market expected to grow with higher pace as growing awareness campaigns for cardiac diseases, increasing electrocardiogram testing, and growing prevalence of heart failure. Asian countries such as India and China expected to grow with highest growth rate over the forecast period.

Heart Failure Testing Market: Key Market Participants

Example of some market players participants in global heart failure testing market find across the value chain are Abbott Laboratories, Response Biomedical, F. Hoffmann-La Roche AG, Trinity Biotech plc., Quidel Corporation, Siemens Healthcare GmbH, bioMérieux SA, GE Healthcare, Koninklijke Philips N.V., Schiller AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, China ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Heart Failure Testing Market: Segmentation

On the basis of test type, heart failure testing market can be segmented as:

• Electrocardiogram
• Blood Test
• B-type natriuretic peptide (BNP)
• proBNP
• NT-proBNP
• Atrial Natriuretic Peptide
• Others

On the basis of product type, heart failure testing market can be segmented as:

• Instruments
• Regents
• POC Testing Kits

On the basis of end users, heart failure testing market can be segmented as:

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cardiac Care Centers